MPC vs NRIX · P/E 16, rev $138.86B vs rev $54.5M
Marathon Petroleum Corp (MPC) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Marathon Petroleum Corp (MPC) is a oil & gas refining & marketing company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported MPC revenue for 2024-12-31 was $138.86B. Net income was $5.07B. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
MPC currently screens at market cap $71.41B and trailing P/E 16.1. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the MPC and NRIX stock pages for the full models.
Not investment advice.